Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is buying fellow ultra orphan drug developer Synageva Biopharma Corp (NASDAQ:GEVA) for $8.
Synageva Biopharma Corp (NASDAQ:GEVA) increased more than 130% to $221.25 in pre-market trading following news that the pharmaceutical company will be acquired by …
In a research note released this morning, Janney Montgomery Scott analyst Kimberly Lee reiterated coverage on Synageva BioPharma Corp. (GEVA) with a Buy rating and raised her fair value estimate …
